Morphosys Ag (MOR) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
MorphoSys AG has announced a significant change in shareholding, with Novartis AG acquiring a new total of 91.04% of voting rights as of June 19, 2024. The acquisition marks a substantial increase from the previous notification, indicating a major shift in the company’s ownership structure. This strategic move by Novartis signals a strong commitment to MorphoSys AG’s future.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
